Yi Guo
Impact in
-
- Antibiotic Use and Resistance
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- Antibiotic Use and Resistance 10
-
- COVID-19 Clinical Research Studies 13
- SARS-CoV-2 and COVID-19 Research 7
Yi Guo
86 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 141
- Applied Microbiology and Biotechnology 175
- Modeling and Simulation 179
- Infectious Diseases 587
- Critical Care and Intensive Care Medicine 92
- Biological Psychiatry 40
Countries citing papers authored by Yi Guo
This map shows the geographic impact of Yi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Guo more than expected).
Fields of papers citing papers by Yi Guo
This network shows the impact of papers produced by Yi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Guo. The network helps show where Yi Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 2 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 203 | |
| 15 | 2019 | 1 | |
| 16 | 2015 | 13 | |
| 17 | 2015 | 12 | |
| 18 | 2013 | 27 | |
| 19 | 2012 | 29 | |
| 20 | 2012 | 55 |
About Yi Guo
Yi Guo is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Critical Care and Intensive Care Medicine, Otorhinolaryngology and Molecular Medicine, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Antibiotic Use and Resistance (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Respiratory Support and Mechanisms (5 papers), Nosocomial Infections in ICU (5 papers), Head and Neck Cancer Studies (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (175 citations), Modeling and Simulation (179 citations), Infectious Diseases (587 citations), Critical Care and Intensive Care Medicine (92 citations) and Biological Psychiatry (40 citations). Yi Guo has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Yaqing Zhou, En‐Zhi Jia, Lei Hua, Jinxia Yuan, Qiaowei Jia, Shu He, Chenhui Zhao, Wendy Szymczak, Can Hou and Rachel Bartash. Their work appears in journals such as Open Forum Infectious Diseases, Oncology Reports, Infection Control and Hospital Epidemiology, Diagnostic Microbiology and Infectious Disease and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.